Selected research
Industry Research
Aciclovir Drug Industry Research Report 2026
Market perspective
The global Aciclovir Drug market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Aciclovir Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Aciclovir Drug is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Aciclovir Drug is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Aciclovir Drug include Yiling Pharmaceutical, SHANGHAI CP GENERAL PHARMACEUTICAL, UNITED LABORATOR IES, Kangzheng Pharmaceutical, Fresenius Kabi, Zydus Pharmaceuticals, Vectans Pharma, Talent Healthcare and RelonChem, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Aciclovir Drug market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Aciclovir Drug Market by Company
Yiling Pharmaceutical
SHANGHAI CP GENERAL PHARMACEUTICAL
UNITED LABORATOR IES
Kangzheng Pharmaceutical
Fresenius Kabi
Zydus Pharmaceuticals
Vectans Pharma
Talent Healthcare
RelonChem
Novus Life Sciences
Cipla
Blue Pharma
Actiza Pharma
Aciclovir Drug Segment by Type
Topical Ointment
Oral Tablet
Lntravenous Dosage Forms
Aciclovir Drug Segment by Application
Shingles
Herpes Simplex Virus Infection
Chickenpox in Immunocompromised Persons
Others
Aciclovir Drug Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Aciclovir Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Aciclovir Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Aciclovir Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Aciclovir Drug manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Aciclovir Drug by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Aciclovir Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Topical Ointment
- Oral Tablet
- Lntravenous Dosage Forms
Applications
- Shingles
- Herpes Simplex Virus Infection
- Chickenpox in Immunocompromised Persons
- Others
Companies covered
- Yiling Pharmaceutical
- SHANGHAI CP GENERAL PHARMACEUTICAL
- UNITED LABORATOR IES
- Kangzheng Pharmaceutical
- Fresenius Kabi
- Zydus Pharmaceuticals
- Vectans Pharma
- Talent Healthcare
- RelonChem
- Novus Life Sciences
- Cipla
- Blue Pharma
- Actiza Pharma
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Aciclovir Drug Market Size (2021-2032)
- 2.2.2 Global Aciclovir Drug Sales (2021-2032)
- 2.2.3 Global Aciclovir Drug Market Average Price (2021-2032)
- 2.3 Aciclovir Drug by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Topical Ointment
- 2.3.3 Oral Tablet
- 2.3.4 Lntravenous Dosage Forms
- 2.4 Aciclovir Drug by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Shingles
- 2.4.3 Herpes Simplex Virus Infection
- 2.4.4 Chickenpox in Immunocompromised Persons
- 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Aciclovir Drug Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Aciclovir Drug Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Aciclovir Drug Revenue of Manufacturers (2021-2026)
- 3.4 Global Aciclovir Drug Average Price by Manufacturers (2021-2026)
- 3.5 Global Aciclovir Drug Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Aciclovir Drug, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Aciclovir Drug, Product Type & Application
- 3.8 Global Manufacturers of Aciclovir Drug, Established Date
- 3.9 Global Aciclovir Drug Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Yiling Pharmaceutical
- 4.1.1 Yiling Pharmaceutical Company Information
- 4.1.2 Yiling Pharmaceutical Business Overview
- 4.1.3 Yiling Pharmaceutical Aciclovir Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Yiling Pharmaceutical Aciclovir Drug Product Portfolio
- 4.1.5 Yiling Pharmaceutical Recent Developments
- 4.2 SHANGHAI CP GENERAL PHARMACEUTICAL
- 4.2.1 SHANGHAI CP GENERAL PHARMACEUTICAL Company Information
- 4.2.2 SHANGHAI CP GENERAL PHARMACEUTICAL Business Overview
- 4.2.3 SHANGHAI CP GENERAL PHARMACEUTICAL Aciclovir Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 SHANGHAI CP GENERAL PHARMACEUTICAL Aciclovir Drug Product Portfolio
- 4.2.5 SHANGHAI CP GENERAL PHARMACEUTICAL Recent Developments
- 4.3 UNITED LABORATOR IES
- 4.3.1 UNITED LABORATOR IES Company Information
- 4.3.2 UNITED LABORATOR IES Business Overview
- 4.3.3 UNITED LABORATOR IES Aciclovir Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 UNITED LABORATOR IES Aciclovir Drug Product Portfolio
- 4.3.5 UNITED LABORATOR IES Recent Developments
- 4.4 Kangzheng Pharmaceutical
- 4.4.1 Kangzheng Pharmaceutical Company Information
- 4.4.2 Kangzheng Pharmaceutical Business Overview
- 4.4.3 Kangzheng Pharmaceutical Aciclovir Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Kangzheng Pharmaceutical Aciclovir Drug Product Portfolio
- 4.4.5 Kangzheng Pharmaceutical Recent Developments
- 4.5 Fresenius Kabi
- 4.5.1 Fresenius Kabi Company Information
- 4.5.2 Fresenius Kabi Business Overview
- 4.5.3 Fresenius Kabi Aciclovir Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Fresenius Kabi Aciclovir Drug Product Portfolio
- 4.5.5 Fresenius Kabi Recent Developments
- 4.6 Zydus Pharmaceuticals
- 4.6.1 Zydus Pharmaceuticals Company Information
- 4.6.2 Zydus Pharmaceuticals Business Overview
- 4.6.3 Zydus Pharmaceuticals Aciclovir Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Zydus Pharmaceuticals Aciclovir Drug Product Portfolio
- 4.6.5 Zydus Pharmaceuticals Recent Developments
- 4.7 Vectans Pharma
- 4.7.1 Vectans Pharma Company Information
- 4.7.2 Vectans Pharma Business Overview
- 4.7.3 Vectans Pharma Aciclovir Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Vectans Pharma Aciclovir Drug Product Portfolio
- 4.7.5 Vectans Pharma Recent Developments
- 4.8 Talent Healthcare
- 4.8.1 Talent Healthcare Company Information
- 4.8.2 Talent Healthcare Business Overview
- 4.8.3 Talent Healthcare Aciclovir Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Talent Healthcare Aciclovir Drug Product Portfolio
- 4.8.5 Talent Healthcare Recent Developments
- 4.9 RelonChem
- 4.9.1 RelonChem Company Information
- 4.9.2 RelonChem Business Overview
- 4.9.3 RelonChem Aciclovir Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 RelonChem Aciclovir Drug Product Portfolio
- 4.9.5 RelonChem Recent Developments
- 4.10 Novus Life Sciences
- 4.10.1 Novus Life Sciences Company Information
- 4.10.2 Novus Life Sciences Business Overview
- 4.10.3 Novus Life Sciences Aciclovir Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Novus Life Sciences Aciclovir Drug Product Portfolio
- 4.10.5 Novus Life Sciences Recent Developments
- 4.11 Cipla
- 4.11.1 Cipla Company Information
- 4.11.2 Cipla Business Overview
- 4.11.3 Cipla Aciclovir Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Cipla Aciclovir Drug Product Portfolio
- 4.11.5 Cipla Recent Developments
- 4.12 Blue Pharma
- 4.12.1 Blue Pharma Company Information
- 4.12.2 Blue Pharma Business Overview
- 4.12.3 Blue Pharma Aciclovir Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Blue Pharma Aciclovir Drug Product Portfolio
- 4.12.5 Blue Pharma Recent Developments
- 4.13 Actiza Pharma
- 4.13.1 Actiza Pharma Company Information
- 4.13.2 Actiza Pharma Business Overview
- 4.13.3 Actiza Pharma Aciclovir Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Actiza Pharma Aciclovir Drug Product Portfolio
- 4.13.5 Actiza Pharma Recent Developments
5 Global Aciclovir Drug Market Scenario by Region
- 5.1 Global Aciclovir Drug Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Aciclovir Drug Sales by Region: 2021-2032
- 5.2.1 Global Aciclovir Drug Sales by Region: 2021-2026
- 5.2.2 Global Aciclovir Drug Sales by Region: 2027-2032
- 5.3 Global Aciclovir Drug Revenue by Region: 2021-2032
- 5.3.1 Global Aciclovir Drug Revenue by Region: 2021-2026
- 5.3.2 Global Aciclovir Drug Revenue by Region: 2027-2032
- 5.4 North America Aciclovir Drug Market Facts & Figures by Country
- 5.4.1 North America Aciclovir Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Aciclovir Drug Sales by Country (2021-2032)
- 5.4.3 North America Aciclovir Drug Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Aciclovir Drug Market Facts & Figures by Country
- 5.5.1 Europe Aciclovir Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Aciclovir Drug Sales by Country (2021-2032)
- 5.5.3 Europe Aciclovir Drug Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Aciclovir Drug Market Facts & Figures by Country
- 5.6.1 Asia Pacific Aciclovir Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Aciclovir Drug Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Aciclovir Drug Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Aciclovir Drug Market Facts & Figures by Country
- 5.7.1 South America Aciclovir Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Aciclovir Drug Sales by Country (2021-2032)
- 5.7.3 South America Aciclovir Drug Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Aciclovir Drug Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Aciclovir Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Aciclovir Drug Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Aciclovir Drug Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Aciclovir Drug Sales by Type (2021-2032)
- 6.1.1 Global Aciclovir Drug Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Aciclovir Drug Sales Market Share by Type (2021-2032)
- 6.2 Global Aciclovir Drug Revenue by Type (2021-2032)
- 6.2.1 Global Aciclovir Drug Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Aciclovir Drug Revenue Market Share by Type (2021-2032)
- 6.3 Global Aciclovir Drug Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Aciclovir Drug Sales by Application (2021-2032)
- 7.1.1 Global Aciclovir Drug Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Aciclovir Drug Sales Market Share by Application (2021-2032)
- 7.2 Global Aciclovir Drug Revenue by Application (2021-2032)
- 7.2.1 Global Aciclovir Drug Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Aciclovir Drug Revenue Market Share by Application (2021-2032)
- 7.3 Global Aciclovir Drug Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Aciclovir Drug Value Chain Analysis
- 8.1.1 Aciclovir Drug Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Aciclovir Drug Production Mode & Process
- 8.2 Aciclovir Drug Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Aciclovir Drug Distributors
- 8.2.3 Aciclovir Drug Customers
9 Global Aciclovir Drug Analyzing Market Dynamics
- 9.1 Aciclovir Drug Industry Trends
- 9.2 Aciclovir Drug Industry Drivers
- 9.3 Aciclovir Drug Industry Opportunities and Challenges
- 9.4 Aciclovir Drug Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst